Bull & Bear
Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Bull and Bear
Verdict: Avoid — you are paying a real-business multiple for audited profits that have never converted to cash, inside a structure where the company sits on both sides of its largest revenue line. Bull and Bear agree on almost every fact; they disagree on what the facts mean. The single tension that decides this name is cash quality: Oriana earns a genuine, peer-beating ~33% ROE, yet free cash flow has been negative for five straight years and the swing to positive operating cash flow was funded by customer and affiliate advances, not collections [1]. The bear carries more weight today because the one event that would resolve the debate — a clean, third-party, cash-settled monetization of the asset base — is exactly what keeps slipping. What would change the conclusion is concrete and observable: a clean arm's-length Actis close plus one year of positive operating cash flow without a fresh advance build. Until both arrive, the discount is the market pricing a value trap, not an opportunity.
Bull Case
The bull case rests on price and quality: Oriana is the lowest-multiple profitable operator in the Indian renewable-EPC cohort while out-earning the group on capital — ~12.7x trailing earnings on FY2026 basic EPS of $1.38 against a ~33% ROE held inside a 31–45% band for five years [2]. It backs that with rare forward visibility — an unexecuted order book near USD 720–740 million, close to four years of FY2026 revenue [3] — and a single re-rating lever: the agreed sale of ~238 MW of operating assets to an Actis entity at ~USD 108m enterprise value, paired with a 1 GW joint-development agreement that keeps Oriana the exclusive EPC and O and M partner [4]. I have dropped Bull's fourth point (margin expansion through the commodity shock); it is real but supporting, not decisive.
Sources: bull points sourced as cited above — FY2026 audited results [5]; Q4 FY2026 analyst meet [6]; Investor Presentation 10 Jun 2026 [7].
Bull's price target is $29.0 (from ~$16.7, ~74% upside), built by applying twin KPI Green's 15.5x multiple to FY2027 EPS of ~$1.87 (~USD 38m net profit at the low end of guidance, excluding any one-time gain on the Actis sale [8]), over a 12–18 month window. Bull's named disconfirming signal: FY2027 free cash flow stays negative and the Actis sale slips a second time with no third-party close.
Bear Case
The bear case is not that profits are fake — it is that they do not turn into cash and a large slice is sold to itself. Operating cash flow only turned positive because customers and affiliates prepaid faster than receivables exploded; strip the working-capital build and cash from operations is deeply negative, and free cash flow after the asset build was negative in every one of the last five years (FY2022–FY2026: −$0.1m, −$4m, −$13m, −$21m, −$8m). The single largest revenue line of FY2025 was the USD 45m "Sale of Solar Power Plant" to promoter-group SPVs the company itself describes as those "where control is intended to be temporary" — about 39% of consolidated revenue, with Oriana simultaneously their developer, seller, lender and guarantor [9]. And the one event the entire bull case rides on — a clean third-party monetization — is what keeps slipping: of ~12 valuation-relevant promises ~7 were missed or deferred, FY26 revenue of USD 202m came in under the USD 222–278m guide, the Actis 238 MWp close was pushed to FY27, and management halved its own forward bar from a 70–100% aspiration to "40–50%." I have dropped Bear's off-balance-sheet-leverage point; it is strong but overlaps the cash-quality argument.
Sources: bear points sourced as cited above — FY2025 Annual Report, Consolidated Cash Flow Statement [10] and Related Party Transactions [11]; Q4 FY2026 analyst meet [12].
Bear's downside target is $10.0 (from ~$16.7, roughly −40%), via multiple compression to ~7.5–8x trailing EPS of $1.38 — an SME accounting-risk and illiquidity discount that puts Oriana below the cleaner profitable EPC cohort (13–15x), with a book-value floor near $3.96 (1.0x FY2026 net worth of USD 85m) if an SPV impairment breaks the gains-on-sale narrative — over the same 12–18 month FY2027 reporting cycle. Bear's named cover signal: a clean, cash-settled, arm's-length third-party monetization on disclosed terms plus one year of positive operating cash flow without a fresh advance build — either alone is insufficient.
The Real Debate
Both sides work from the same three facts. The disagreement is interpretive, and each tension resolves on something observable in the FY2027 record.
Sources: shared facts traced to the FY2025 Annual Report — Consolidated Cash Flow Statement [13] and Related Party Transactions [14] — and the Investor Presentation 10 Jun 2026 [15].
Verdict
Avoid. The bear carries more weight because all three tensions resolve on the same missing proof, and that proof has not yet arrived: profits that do not convert to cash, a largest-revenue-line sold to entities the company controls, and a re-rating event that has already slipped once. The most important tension is the first — cash quality — because it is upstream of the others: if FY2027 operating cash flow stays positive only because advances jumped again, then the 39% related-party revenue and the Actis "validation" are both circular, and the cheap multiple is cheap for a reason. The bull could still be right, and the path is clean: Oriana genuinely earns a ~33% ROE on a growing equity base, the audit is unqualified, founders own ~58% and have sold nothing, and Actis is a real institutional counterparty — if the 238 MW closes to a third party for cash and the next year's cash flow is advance-free, this re-rates hard and the discount was the opportunity. The durable thesis breaker is the cash-quality test: one year of positive operating cash flow with receivables and CFO moving together. The near-term evidence marker is narrower and comes first: the Actis 238 MW closing clean, cash-settled, arm's-length, on disclosed terms. A clean close plus advance-free cash flow would flip this to Lean Long; a second slip, a promoter-group buyer, or another advance-funded CFO print confirms the value trap. Until the cash speaks, judgment outweighs the multiple.
Avoid — a genuine ~33% ROE and a four-year order book do not offset five years of negative free cash flow and a largest-revenue-line sold to promoter-group SPVs; wait for a clean, cash-settled third-party Actis close plus one advance-free year of operating cash flow before owning it.